Retinal pigment epithelial tear following intravitreal injection of bevacizumab (avastin®): Optical coherence tomography and fluorescein angiographic findings [6]

Eye

Volumn 21, Issue 7, 2007, Pages 1004-1005

  Mathews, J P ^a   Jalil, A ^a   Lavin, M J ^a   Stanga, P E ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGED; CASE REPORT; FEMALE; HUMAN; LETTER; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 34447310008     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702805     Document Type: Letter

References (6)

1. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004; 3(5): 391-400.
2. Lommatzsch A, Radermacher M, Spital G, Pauleikheoff D. Photodynamic therapy of pigment epithelium detachments in AMD (ARVO abstract). Invest Ophthamol Vis Sci 2002; (Suppl): 439.
3. Copt RP, Zografos L. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularisation caused by age-related macular degeneration (ARVO ,abstract). Invest Ophthalmol Vis Sci 2002; (Suppl): 440.
4. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularisation. Am J Ophthalmol 2001; 131: 518-520.
5. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001; 21: 661-665.
6. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141(4): 752-754.